Functional analysis of HPV-like particle-activated langerhans cells in vitro

Cervical Cancer: Methods and Protocols

Volumn , Issue , 2014, Pages 333-350

  Yan, Lisa ^a   Woodham, Andrew W ^a   Da Silva, Diane M ^a   Martin Kast, W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antigen specific T cells; ELISpot; HPV16; In vitro immunization; Langerhans cells; Migration

Indexed keywords

EID: 84921764119     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-2013-6_25     Document Type: Chapter

References (16)

1. Walboomers JMM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1): 12-19
2. Bosch F, Manos M, Munoz N, Sherman M, Jansen A, Peto J, Schiffman M, Moreno V, Kurman R, Shah K (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Servical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802
3. Stanley MA, Pett MR, Coleman N (2007) HPV: from infection to cancer. Biochem Soc Trans 35(6): 1456-1460
4. Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8(12): 935-947
5. Cumming SA, Cheun-Im T, Milligan SG, Graham SV (2008) Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation. Biochem Soc Trans 36:522-524
6. Kirnbauer R et al (1992) Papillomavirus L1 major capsid protein self-assembles into viruslike particles that are highly immunogenic. Proc Natl Acad Sci U S A 89(24): 12180-12184
7. Buck CB et al (2008) Arrangement of L2 within the papillomavirus capsid. J Virol 82(11): 5190-5197
8. Fahey LM et al (2009) A major role for the minor capsid protein of human papillomavirus type 16 in immune escape. J Immunol 183(10): 6151-6156
9. Yan M et al (2004) Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology 324(2): 297-310
10. Fausch SC et al (2002) Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses. J Immunol 169(6): 3242-3249
11. Fausch SC, Da Silva DM, Kast WM (2003) Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res 63:3478-3482
12. Fausch SC et al (2005) Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation. J Immunol 174(11): 7172-7178
13. Peiser M et al (2008) Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4 + T cell stimulatory capacity. J Leukoc Biol 83(5): 1118-1127
14. Larsen CP et al (1990) Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172(5): 1483-1493
15. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392(6671): 86-89
16. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673): 245-252